Connexion
E-mail
Mot de passe
Afficher le mot de passe
Retenir
Mot de passe oublié ?
Devenir membre gratuitement
Inscription
Inscription
Devenir membre
Inscription gratuite
Devenir client
Découvrez nos services
Paramètres
Paramètres
Cotations dynamiques 
OFFON

ITERUM THERAPEUTICS PLC

(ITRM)
  Rapport
SynthèseCotationsGraphiquesActualitésNotationsAgendaSociétéFinancesConsensusRévisionsDérivésFondsCommunauté 
SynthèseToute l'actualitéReco analystesAutres languesCommuniquésPublications officiellesActualités du secteur
Actualités dans d'autres langues sur ITERUM THERAPEUTICS PLC
2021Iterum Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
2021Iterum Therapeutics Appoints Sailaja Puttagunta, MD as Chief Medical Officer
2021Iterum Therapeutics plc Appoints Sailaja Puttagunta as Chief Medical Officer
2021ITERUM THERAPEUTICS PLC Management's Discussion and Analysis of Financial Condition an..
2021Iterum Therapeutics Reports Third Quarter 2021 Financial Results and Provides Business ..
2021Iterum Therapeutics plc Reports Earnings Results for the Third Quarter and Nine Months ..
2021Earnings Flash (ITRM) ITERUM THERAPEUTICS Reports Q3 Loss $-0.03, vs. Street Est of $-0..
2021Iterum Therapeutics Reports Third Quarter 2021 Financial Results and Provides Business ..
2021Iterum Therapeutics to Provide Business Update and Report Third Quarter 2021 Financial ..
2021Top Premarket Gainers
2021ITERUM THERAPEUTICS : Evaluating Optimal Design for Additional Late-Stage UTI Drug Trial A..
2021ITERUM THERAPEUTICS : Provides Update from FDA Type A Meeting Regarding Oral Sulopenem
2021Iterum Therapeutics Provides Update from FDA Type A Meeting Regarding Oral Sulopenem
2021ITERUM THERAPEUTICS : to Present Data at IDWeek 2021
2021ITERUM THERAPEUTICS PLC(NASDAQCM : ITRM) added to S&P Global BMI Index
2021ITERUM THERAPEUTICS : Delisting/Transfer of Listing (Form 8-K)
2021ITERUM THERAPEUTICS PLC : Notice of Delisting or Failure to Satisfy a Continued Listing Ru..
2021ITERUM THERAPEUTICS : to Present at the H.C. Wainwright 23rd Annual Global Investment Conf..
2021SHAREHOLDER ALERT : Robbins LLP Announces that Iterum Therapeutics PLC (ITRM) is Being Sue..
2021ITERUM THERAPEUTICS : Management's Discussion and Analysis of Financial Condition and Resu..
2021Iterum Therapeutics plc Reports Earnings Results for the Second Quarter Ended June 30, ..
2021ITERUM THERAPEUTICS : Earnings Flash (ITRM) ITERUM THERAPEUTICS Posts Q2 Loss $-0.04, vs. ..
2021Iterum Therapeutics Reports Second Quarter 2021 Financial Results and Provides Business..
2021Iterum Therapeutics to Provide Business Update and Report Second Quarter 2021 Financial..
2021ITERUM THERAPEUTICS : Receives Complete Response Letter from U.S. Food and Drug Administra..
2021ITERUM THERAPEUTICS PLC : Other Events, Financial Statements and Exhibits (form 8-K)
2021SECTOR UPDATE : Health Care Stocks Sinking Monday
2021Top Midday Decliners
2021SECTOR UPDATE : Health Care Stock Sputtering, Led Lower by Biotech Shares
2021Iterum Therapeutics Shares Drop 40% After FDA Letter for Sulopemen NDA
2021ITERUM THERAPEUTICS : New-Drug Application for Oral Sulopenem Fails to Receive FDA Approva..
2021Top Premarket Decliners
2021ITERUM THERAPEUTICS : Receives Complete Response Letter from U.S. Food and Drug Administra..
2021Iterum Therapeutics plc Receives Complete Response Letter from U.S. Food and Drug Admin..
2021ITERUM THERAPEUTICS : FDA Recommends More Data on Oral Sulopenem
2021SHAREHOLDER ALERT : Pomerantz Law Firm Investigates Claims On Behalf of Investors of Iteru..
2021SECTOR UPDATE : Health Care Stocks Advance Pre-Bell Friday
2021Wall Street Sees Positive Open as Nonfarm Payrolls Rise More Than Expected
2021ITERUM THERAPEUTICS : Provides Regulatory Update (Form 8-K)
2021ITERUM THERAPEUTICS PLC : Other Events, Financial Statements and Exhibits (form 8-K)
2021Iterum Says FDA Found Deficiencies in Drug Application
2021ITERUM THERAPEUTICS : Says FDA Identified Deficiencies in Sulopenem NDA
2021Iterum Therapeutics Provides Regulatory Update
2021Iterum Therapeutics plc Receives Letter from the U.S. Food and Drug Administration as P..
2021ITERUM THERAPEUTICS PLC : Change in Directors or Principal Officers, Submission of Matters..
2021ITERUM THERAPEUTICS PLC : Change in Directors or Principal Officers, Other Events (form 8-..
2021ITERUM THERAPEUTICS : Departure of Directors or Certain Officers; Appointment of Certain O..
2021Iterum Therapeutics plc Announces Resignation of Shahzad Malik from the Board of Direct..
2021AFTER HOURS WATCH LIST SCORECARD : Itrm, yext, hpq,
2021SECTOR UPDATE : Health Care Stocks Lose Early Luster Heading into Friday Close
2021SECTOR UPDATE : Health Care Stocks' Gains Bracing Broader Market
2021MIDDAY REPORT : Wall Street Higher Midday, Ignores Inflation Gauge Spike
2021SECTOR UPDATE : Health Care Stocks Advance Premarket Friday
2021Wall Street Set for Gains, Buoyed by Improving Jobless Claims
2021SECTOR UPDATE : Health Care
2021MT NEWSWIRES AFTER HOURS WATCH LIST : Itrm, yext, hpq
2021ITERUM THERAPEUTICS : Says FDA Not Seeking Advisory Committee Review for Sulopenem Drug Ap..
2021ITERUM THERAPEUTICS : Provides Update on NDA Review (Form 8-K)
2021ITERUM THERAPEUTICS PLC : Other Events, Financial Statements and Exhibits (form 8-K)
2021Iterum Therapeutics Provides Update on NDA Review
2021Iterum Therapeutics plc Provides Update on NDA Review
2021ITERUM THERAPEUTICS : Management's Discussion and Analysis of Financial Condition and Resu..
2021Iterum Therapeutics plc Reports Earnings Results for the First Quarter Ended March 31, ..
2021ITERUM THERAPEUTICS : Earnings Flash (ITRM) ITERUM THERAPEUTICS Posts Q1 Loss $-0.05, vs. ..
2021Iterum Therapeutics Reports First Quarter 2021 Financial Results
2021Iterum Therapeutics to Provide Business Update and Report First Quarter 2021 Financial ..
2021ITERUM THERAPEUTICS : US FDA Postpones Panel Review of Iterum Application for Sulopenem Et..
2021ITERUM THERAPEUTICS PLC : Other Events (form 8-K)
2021Iterum Therapeutics plc Provides Update on Notice from U.S. Food and Drug Administratio..
2021Iterum Therapeutics to Present at the 20th Annual Needham Virtual Healthcare Conference
2021Iterum Therapeutics Appoints Beth P. Hecht to Board of Directors
2021Iterum Therapeutics Appoints Beth P. Hecht to Board of Directors
2021ITERUM THERAPEUTICS : Earnings Flash (ITRM) ITERUM THERAPEUTICS Reports Q4 Loss $-0.11, vs..
2021Iterum Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results
2021Iterum Therapeutics plc Reports Earnings Results for the Fourth Quarter Ended December ..
1  2  3Suiv.
Prochain événement sur ITERUM THERAPEUTICS PLC